-
-
Archive: ‘Scientifically Fearless’ Cancer Researcher Zena Werb Dies at 75
Colleagues are mourning the passing of Zena Werb, PhD, a giant in the field of cancer biology whose four decades of research at UCSF informed the rise of immunotherapy and other modern approaches to cancer treatment.
-
Archive: AIDS 2020: UCSF Experts to Speak, Present at International Conference
Dozens of UCSF infectious disease experts will present at the bi-annual International AIDS Conference, known this year as AIDS 2020.
-
Archive: Physical Activity Dropped Worldwide During COVID-19, Raising Concerns for Health
The declaration of COVID-19 as a global pandemic in March resulted in a rapid decrease in step counts worldwide.
-
Archive: San Quentin Prison Was Free of the Virus. One Decision Fueled an Outbreak.
-
Archive: UCSF Health Remembers Bertram Lubin, Former President of Children’s Hospital Oakland
Bertram Lubin, former president and chief executive officer of UCSF Benioff Children’s Hospital Oakland, passed away peacefully, surrounded by family, on June 27, 2020.
-
Archive: COVID-19 Relies on Cell’s ‘Master Regulators’ for Survival
UCSF scientists assembled an international research team that has figured out how SARS-CoV-2, the virus that causes COVID-19, hijacks proteins in host cells that serve as master regulators of key cellular processes.
-
Archive: LGBTQ+ Populations Experience Newfound Anxiety and Depression in COVID-19 Pandemic
LGBTQ+ communities have experienced increased anxiety and depression since the onset of the COVID-19 pandemic, especially those who haven’t struggled with these conditions before.
-
Archive: Living With COVID-19 When It Won't Go Away
-
Archive: Update on IT Security Incident at UCSF
UCSF IT staff detected a security incident that occurred in a limited part of the UCSF School of Medicine’s IT environment on June 1.
-
Archive: Telehealth and the COVID-19 Pandemic: Enhancing Care and Education
The use of telehealth, sharing medical information and communicating electronically, has increased dramatically in the wake of the COVID-19 pandemic
-
Archive: What Is Pooled Testing? How Lessons from the HIV Epidemic Could Help Fight the Coronavirus
-
Archive: Still Confused About Masks? Here’s the Science Behind How Face Masks Prevent Coronavirus
We talked to UCSF epidemiologist George Rutherford, MD, and infectious disease specialist Peter Chin-Hong, MD, about the CDC’s reversal on mask-wearing, the current science on how masks work, and what to consider when choosing a mask.
-
Archive: No Coronavirus Spike From Black Lives Matter Protests in Bay Area, Experts Say
-
Archive: Newly Diagnosed COVID-19 Patients Needed for Antibiotic Clinical Trial
The nationwide clinical trial will assess whether the common antibiotic azithromycin can reduce hospitalization stays and death caused by the SARS-CoV-2 virus.
-
Archive: Dementia May Develop 7 Years Earlier for Adults with Inflammatory Bowel Disease
Older adults with chronic inflammation of the gastrointestinal tract may develop dementia more than seven years earlier than those without the condition.
-
Archive: Dexamethasone and the Recovery Trial's High-Speed Science
-
Archive: People With Inflammatory Bowel Disease Might Be at Higher Risk for Dementia, Study Finds
-
Archive: Hellman Fellows Program and UC Announce Historic $125M Commitment to Junior Faculty Research
The Hellman Fellows Program and the University of California announced a plan to permanently support the Hellman Fellows Program on all 10 campuses in the UC system.
-
Archive: Can People Spread the Coronavirus If They Don't Have Symptoms? 5 Questions Answered About Asymptomatic COVID-19
-
Archive: Inequality Fueled COVID-19 Transmission in San Francisco’s Mission District, Says New Study
In the first six weeks of San Francisco’s shelter-in-place ordinance, continued spread of COVID-19 was increasingly concentrated among low-income Latinx people who were unable to work from home.
-
Archive: Bay Area Doctors Worry About Patients Skipping Preventive Medical Care During Coronavirus Pandemic
-
Archive: Recombinant Antibody Network Partners with Bristol Myers Squibb to Develop Novel Therapies
Under a new agreement, Celgene will further invest in the RAN’s state-of-the-art antibody engineering program to expand target discovery from oncology and immunology to include neurology.
-
Archive: UC Celebrates Supreme Court Win for DACA Students
The University of California applauds the U.S. Supreme Court’s decision to strike down the Trump administration’s arbitrary attempt to end a program that allowed immigrants brought to the U.S. as children to live and work in the country they know as home.
-
Archive: UCSF Update on IT Security Incident
On June 1, UCSF IT staff identified and stopped an unauthorized access of a limited part of the School of Medicine’s IT environment while the intrusion was occurring.
-
Archive: The Lasting Effects of Having – Or Being Denied – An Abortion
-
Archive: UCSF, St. Jude Identify Key Culprit Driving Treatment Resistance in Deadly Immune Disorder
The finding could offer additional insights into other immune conditions, including a type of childhood leukemia and the severe inflammation response in some children with COVID-19.
-
Archive: Transformative Deal with Leading Scientific Publisher Will Make UC Research Freely Accessible to All
University of California announced that it has struck a transformative “open access” deal with Springer Nature, the world’s second largest publisher of academic journals.
-
Archive: UCSF Benioff Children’s Hospitals Rank Among the Nation’s Best for 10 Specialties in 2020-2021 U.S. News & World Report
The annual U.S. News rankings serve as a guide of hospitals nationwide that excel in treating children with the most challenging diagnoses.
-
Archive: FDA Approves Video Game Based on UCSF Brain Research as ADHD Therapy for Kids
The FDA has approved the first video game therapeutic as a treatment for attention deficit hyperactivity disorder (ADHD) in children, based on research by UCSF’s Adam Gazzaley, MD, PhD.